Home / Business and Economy / CVS Health Surges Past S&P 500 Benchmarks
CVS Health Surges Past S&P 500 Benchmarks
29 Nov, 2025
Summary
- CVS Health stock climbed 77.9% year-to-date.
- Company's Q3 revenue exceeded expectations at $102.9 billion.
- Full-year EPS guidance was raised by management.
CVS Health, a major healthcare platform, has shown impressive stock performance, significantly outperforming broader market benchmarks. Year-to-date, the company's stock has surged by 77.9%, outpacing the S&P 500 Healthcare Sector SPDR. This strong growth reflects its integrated care model, expanding telehealth services, and cost-efficient operations.
Recently, CVS Health reported robust third-quarter fiscal year 2025 earnings, with revenue climbing to $102.9 billion, exceeding analysts' expectations. Although a significant non-cash goodwill impairment charge impacted the results, the company also raised its full-year adjusted earnings per share guidance, signaling confidence in its ongoing financial trajectory.
Technically, CVS Health's stock has maintained a consistent upward trend, trading above key moving averages for extended periods. The company's strategic focus on healthcare delivery, pharmacy benefits, and insurance through entities like Aetna and Oak Street Health underpins its strong market position and investor appeal.
